CBIO Crescent Biopharma, Inc. - Common Stock
NASDAQ · Biotechnology · Lihat di SEC EDGAR ↗ tutup Okt 2, 2026 10-K/10-Q Jul 30, 2026
$14,32
· % dari rentang 52 mgg
· di atas terendah
· ke tinggi
$8,72rendah 52m
$27,41tinggi 52m
Kapitalisasi Pasar (MRQ)
$397M
P/E
-29.2
EPS
$-0.59
Pendapatan
$11M
lencana Anda
Rentang 52M
$9–$27
Peringkat Analis
BUY
Target Harga
$31
P/E
-29.2
ROE
-90.0%
Margin Laba Bersih
-1419.6%
Strip lencana Anda kosong — sematkan metrik di mana saja di halaman ini.
CBIO Cuplikan Saham Harga, kapitalisasi pasar, P/E, EPS, ROE, utang/ekuitas, kisaran 52 minggu
Harga
$14.32
Kapitalisasi Pasar (MRQ)
$397M
P/E
-29.2
EPS
$-0.59
Pendapatan
$11M
ROE
-90.0%
Rentang 52M
$9–$27
CBIO Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda
rentang
batang
Granularitas batang menyesuaikan dengan periode yang dipilih — arahkan kursor ke bagan untuk melihat buka/tinggi/rendah/tutup untuk sebuah batang.
Pemecahan saham
| Tanggal ex-dividen | Pemecahan | Tipe |
|---|---|---|
| 16 Juni 2025 | 1-for-100 | Terbalik |
Kinerja 10 Tahun Tren Pendapatan, laba bersih, margin, dan EPS
Pendapatan$11M2016-12-31 → 2025-12-31
EPS$-0.592019-12-31 → 2024-12-31
Arus Kas Bebas$-72M2016-12-31 → 2025-12-31
Margin bersih-1419.6%2016-12-31 → 2025-12-31
Valuasi & Rasio
Valuasi Rasio P/E, P/S, P/B, EV/EBITDA — apakah sahamnya mahal atau murah?
| Metrik | Tren 5 Tahun | CBIO | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| P/E | -29.2rata-rata 5T ≈-186.2 | ≈-186.2 | · | · | |
| P/S | 36.4rata-rata 5T ≈436476.1 | ≈436476.1 | 144.0 | Kurang nilai | |
| P/B (MRQ) | 2.4rata-rata 5T ≈235.3 | ≈235.3 | 3.0 | Nilai wajar | |
| Harga / FCF (TTM) | -5.4rata-rata 5T ≈-195.4 | ≈-195.4 | · | · | |
| Harga / Arus Kas (TTM) | -5.5rata-rata 5T ≈-195.6 | ≈-195.6 | · | · | |
| Price / Tangible Book (Harga / Nilai Buku Berwujud) | 1.9rata-rata 5T ≈218.3 | ≈218.3 | · | · |
Median rekan dihitung berdasarkan basis standar per metrik dan mungkin tidak selalu cocok dengan basis TTM/MRQ yang ditampilkan untuk saham ini.
Profitabilitas Margin kotor, operasional, dan bersih; ROE, ROA, ROIC
| Metrik | Tren 5 Tahun | CBIO | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Operating Margin (Margin Operasi) | -1407.5%rata-rata 5T ≈-115708.9% | ≈-115708.9% | -2380.1% | Sejajar | |
| EBITDA Margin (Margin EBITDA) | -1407.5%rata-rata 5T ≈-115708.9% | ≈-115708.9% | -2380.1% | Sejajar | |
| Pretax Margin (Margin Sebelum Pajak) | -1401.2% | · | -5050.3% | Tingkat teratas | |
| Net Profit Margin (Margin Laba Bersih) | -1419.6%rata-rata 5T ≈-109533.6% | ≈-109533.6% | -2240.9% | Sejajar | |
| ROA | -111.6%rata-rata 5T ≈-87.8% | ≈-87.8% | -40.8% | Lemah | |
| ROE | -90.0%rata-rata 5T ≈-447.8% | ≈-447.8% | -52.8% | Lemah | |
| ROIC | -76.2% | · | -39.0% | Lemah |
Kesehatan Keuangan Utang, likuiditas, solvabilitas — kekuatan neraca
| Metrik | Tren 5 Tahun | CBIO | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Rasio Lancar (MRQ) | 9.7rata-rata 5T ≈5.7 | ≈5.7 | 12.9 | Likuiditas rendah | |
| Quick Ratio (Rasio Cepat) | 6.4rata-rata 5T ≈5.5 | ≈5.5 | 10.5 | Sejajar |
Pertumbuhan Pertumbuhan Pendapatan, EPS, dan Laba Bersih: YoY, CAGR 3T, CAGR 5T
| Metrik | Tren 5 Tahun | CBIO | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Revenue YoY (Pendapatan YoY) | -86.7%rata-rata 5T ≈-89.6% | ≈-89.6% | · | · | |
| Revenue CAGR 3Y (CAGR Pendapatan 3T) | 424.9% | · | · | · | |
| Revenue CAGR 5Y (CAGR Pendapatan 5T) | 1.3% | · | · | · |
Efisiensi Modal Perputaran aset, perputaran persediaan, perputaran piutang
| Metrik | Tren 5 Tahun | CBIO | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Asset Turnover (Perputaran Aset) | 0.1rata-rata 5T ≈0.0 | ≈0.0 | 0.0 | Tingkat teratas | |
| Receivables Turnover (Perputaran Piutang) | 1.2 | · | · | · | |
| Revenue / Employee (Pendapatan Tahunan ÷ karyawan (jumlah karyawan, yfinance). Turunan — bukan konsep SEC-XBRL yang tersimpan.) | ≈$157.2K | · | · | · |
nilai · ≈ rata-rata 5T · median industri · penilaian relatif terhadap median
Dividen Yield, rasio pembayaran, riwayat dividen, CAGR 5 tahun
Pembayaran Tahunan≈$96.00
| Tanggal ex-dividen | Jumlah | Mata Uang | Imbal Hasil |
|---|---|---|---|
| Jan 13, 2023 | $24,00 | USD | ≈55.3% |
| Sep 21, 2022 | $143,00 | USD | ≈223.4% |
Riwayat Pendapatan EPS aktual vs perkiraan, kejutan %, tingkat keberhasilan, tanggal pendapatan berikutnya
Kejutan Rata-rata
-0.05%
Laporan Berikutnya
Nov 04, 2026
| Periode | Laporan | EPS Aktual | EPS Estimasi | Kejutan |
|---|---|---|---|---|
| 30 Juni 2026 | $-0.74 | $-0.81 | 8.7% | |
| 31 Maret 2026 | $-0.70 | $-0.97 | 27.5% | |
| 31 Des. 2025 | $-0.54 | $-2.57 | 79.0% | |
| 30 Sep. 2025 | $-1.27 | $-2.02 | 37.2% | |
| 30 Juni 2025 | $-4.93 | $-1.80 | -174.2% | |
| 31 Maret 2025 | $-4.00 | $-5.10 | 21.6% |
Fundamental Lengkap Semua metrik per tahun — laporan laba rugi, neraca, arus kas
Laporan Laba Rugi
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $11M | · | $10.0K | $75.0K | $1M | $10M | · | · | · | $18.5K | $20M | $15M | |
| R&D Expense | $138M | $14M | $20M | $28M | $47M | $45M | $47M | $40M | $24M | $23M | $25M | $20M | |
| SG&A Expense | $25M | $18M | $19M | $19M | $17M | $17M | $14M | $11M | $10M | $9M | $8M | $7M | |
| Operating Expenses | $163M | $40M | $39M | $47M | $65M | $62M | $61M | $52M | $34M | $32M | $33M | $26M | |
| Operating Income | $-153M | $-40M | $-39M | $-47M | $-63M | $-52M | $-61M | $-52M | $-34M | $-32M | $-13M | $-11M | |
| Other Non-op | · | $2M | $2M | · | · | · | · | · | $651.2K | $103.6K | $15.3K | $18.2K | |
| Pretax Income | $-152M | · | · | · | · | · | · | · | · | · | · | · | |
| Income Tax | $2M | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income | $-154M | $-38M | $-37M | $-47M | $-63M | $-51M | $-58M | $-48M | $-33M | $-32M | $-13M | $-11M | |
| EPS (Basic) | · | $-0.59 | $-0.58 | $-0.89 | $-1.23 | $-1.12 | $-1.34 | · | · | · | · | $-0.60 | |
| EPS (Diluted) | · | $-0.59 | $-0.58 | $-0.89 | $-1.23 | $-1.12 | $-1.34 | · | · | · | · | $-0.60 | |
| Shares (Basic) | · | 64,477,249 | 63,342,465 | 52,531,173 | 51,453,204 | 45,721,139 | 43,254,782 | · | · | · | · | 18,452,252 | |
| Shares (Diluted) | · | 64,477,249 | 63,342,465 | 52,531,173 | 51,453,204 | 45,721,139 | 43,254,782 | · | · | · | · | 18,452,252 | |
| EBITDA | $-153M | $-40M | $-39M | $-47M | $-63M | $-52M | $-61M | $-52M | $-34M | $-32M | $-13M | $-11M |
Neraca
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $213M | $35M | $42M | $48M | $90M | $137M | $158M | $210M | $124M | $40M | $47M | $55M | |
| Receivables | $18M | $0 | · | · | · | · | · | · | · | · | · | · | |
| Prepaid Expense | $5M | $38.0K | $2M | $3M | $533.8K | $1M | $4M | $2M | $3M | $478.5K | $441.8K | $916.2K | |
| Other Current Assets | $5M | $38.0K | · | · | · | · | · | · | · | · | · | · | |
| Current Assets | $237M | $35M | $44M | $51M | $91M | $138M | $163M | $212M | $127M | $41M | $47M | $56M | |
| PP&E (Net) | $846.0K | $0 | · | $242.4K | $368.8K | $620.7K | $822.9K | $957.2K | $1M | $1M | $521.4K | $452.3K | |
| PP&E (Gross) | · | · | · | $3M | $3M | $3M | $3M | $3M | $2M | $2M | $1M | $1M | |
| Accum. Depreciation | · | · | · | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $902.1K | $905.5K | |
| Other Non-current Assets | $1M | $813.0K | · | · | · | · | · | · | · | · | · | · | |
| Total Assets | $240M | $36M | $45M | $52M | $94M | $143M | $168M | $215M | $129M | $42M | $48M | $57M | |
| Accounts Payable | · | $329.3K | $868.1K | $970.2K | $2M | $2M | $1M | $3M | $3M | $2M | $564.2K | $874.0K | |
| Accrued Liabilities | $16M | $2M | $5M | $7M | $9M | $9M | $9M | $6M | $4M | $3M | $6M | $5M | |
| Current Liabilities | $36M | $10M | $7M | $9M | $12M | $12M | $11M | $9M | $8M | $6M | $8M | $6M | |
| Capital Leases | $1M | $0 | $66.8K | · | $918.6K | $2M | $3M | · | · | · | · | · | |
| Total Liabilities | $37M | $47M | $7M | $9M | $13M | $15M | $14M | $9M | $9M | $7M | $8M | $6M | |
| Common Stock | $28.0K | $1.0K | $64.4K | $54.4K | $52.3K | $49.0K | $43.5K | $43.2K | $34.4K | $23.2K | $19.0K | $18.9K | |
| Paid-in Capital | $371M | $2M | $495M | $462M | $454M | $438M | $413M | $406M | $272M | $154M | $128M | $125M | |
| Retained Earnings | $-172M | $-18M | $-456M | $-420M | $-373M | $-309M | $-258M | $-201M | $-152M | $-119M | $-87M | $-74M | |
| Stockholders' Equity | $203M | $-15M | $38M | $43M | $82M | $128M | $154M | $205M | $120M | $35M | $40M | $51M | |
| Liabilities + Equity | $240M | $36M | $45M | $52M | $94M | $143M | $168M | $215M | $129M | $42M | $48M | $57M | |
| Shares Outstanding | 27,556,767 | 1,018,604 | 64,393,744 | 54,377,798 | 52,313,894 | 49,017,622 | 43,466,933 | 43,160,751 | 34,359,799 | 23,250,023 | 19,050,204 | 18,939,838 |
Arus Kas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $13M | $5M | $4M | $4M | $6M | $7M | $6M | $5M | $4M | $3M | $2M | $2M | |
| Deferred Tax | $0 | · | · | · | · | · | · | · | · | · | · | · | |
| Restructuring | · | $7M | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-72M | $-31M | $-35M | $-46M | $-57M | $-39M | $-52M | $-43M | $-30M | $-30M | $-8M | $-4M | |
| CapEx | $919.0K | $10.0K | $21.4K | $84.2K | $14.9K | $68.5K | $144.9K | $125.6K | $294.1K | $704.2K | $268.6K | $212.6K | |
| Investing Cash Flow | $-73M | $20.0K | $-21.4K | $-84.2K | $-14.9K | $-68.5K | $-144.9K | $-125.6K | $-294.1K | $-704.2K | $-268.6K | · | |
| Stock Issued | $0 | · | $29M | $4M | $11M | $18M | · | $128M | $114M | $24M | · | $57M | |
| Net Stock Activity | $0 | · | $29M | $4M | $11M | $18M | · | $128M | $114M | $24M | · | $57M | |
| Financing Cash Flow | $323M | $5.4K | $29M | $4M | $11M | $18M | $412.9K | $129M | $114M | $24M | $114.1K | · | |
| Net Change in Cash | $179M | $-31M | $-6M | $-42M | $-47M | $-21M | $-52M | $86M | $84M | $-7M | $-8M | $53M | |
| Free Cash Flow | $-72M | $-31M | $-35M | $-47M | $-58M | $-39M | $-52M | $-43M | $-30M | $-30M | $-9M | $-4M |
Profitabilitas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -1407.5% | · | -392752.9% | -63204.4% | -5470.7% | -506.8% | · | · | · | -172505.3% | -63.7% | -74.1% | |
| Net Margin | -1419.6% | · | -368994.2% | -62251.7% | -5469.0% | -502.1% | · | · | · | -171945.1% | -63.6% | -74.0% | |
| Pretax Margin | -1401.2% | · | · | · | · | · | · | · | · | · | · | · | |
| EBITDA Margin | -1407.5% | · | -392752.9% | -63204.4% | -5470.7% | -506.8% | · | · | · | -172505.3% | -63.7% | -74.1% | |
| ROA | -111.6% | -134.3% | -76.0% | -63.9% | -53.5% | -32.8% | -30.2% | -28.1% | -38.9% | -70.0% | -24.2% | -35.6% | |
| ROE | -90.0% | -1888.5% | -86.9% | -102.6% | -71.2% | -38.3% | -36.0% | -22.8% | -42.9% | -84.0% | -28.0% | -41.4% | |
| ROIC | -76.2% | · | · | · | · | · | · | · | · | · | · | · |
Likuiditas & Solvabilitas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 6.6 | 1.9 | 6.4 | 5.7 | 7.7 | 11.1 | 14.8 | 24.2 | 15.6 | 6.4 | 6.1 | 8.7 | |
| Quick Ratio | 6.4 | 1.9 | 6.1 | 5.4 | 7.6 | 11.0 | 14.4 | 24.0 | 15.2 | 6.3 | 6.0 | 8.5 |
Efisiensi
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | · | 0.0 | 0.0 | 0.0 | 0.1 | · | · | · | 0.0 | 0.4 | 0.5 | |
| Receivables Turnover | 1.2 | · | · | · | · | · | · | · | · | · | · | · |
Per Saham
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $7.37 | $0.08 | $0.60 | $0.79 | $1.56 | $2.62 | $3.55 | $4.76 | $3.48 | $1.52 | $2.12 | $2.68 | |
| Revenue / Share | · | · | $0.00 | $0.00 | $0.02 | · | · | · | · | · | · | $0.81 | |
| Cash Flow / Share | · | $-0.48 | $-0.55 | $-0.88 | $-1.12 | · | · | · | · | · | · | $-0.23 | |
| Cash / Share | $7.74 | $0.17 | $0.65 | $0.88 | $1.73 | $2.80 | $3.64 | $4.86 | $3.61 | $1.72 | $2.46 | $2.91 | |
| EPS (TTM) | $-0.49 | $-0.59 | $-0.58 | $-0.89 | $-1.23 | $-1.12 | $-1.34 | $-0.75 | $-0.75 | $-0.75 | $-0.71 | $-0.60 |
Tingkat Pertumbuhan
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | · | · | -86.7% | -93.5% | -88.6% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 424.9% | · | -90.0% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 1.3% | · | · | · | · | · | · | · | · | · | · | · |
Valuasi (TTM)
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $11M | · | $10.0K | $75.0K | $1M | $10M | · | · | · | $18.5K | $20M | $15M | |
| Net Income TTM | $-154M | $-38M | $-37M | $-47M | $-63M | $-51M | $-58M | $-48M | $-33M | $-32M | $-13M | $-11M | |
| Market Cap | $327M | $1.61B | $15.20B | $16.48B | $7.53B | $18.43B | $22.99B | $40.87B | $57.69B | $14.18B | $10.90B | $13.64B | |
| P/E | -24.2 | -42.4 | -406.9 | -340.4 | -117.1 | -335.7 | -394.8 | -1262.7 | -2238.7 | -813.3 | -805.6 | -1200.0 | |
| P/S | 30.1 | · | 1519692.4 | 219686.3 | 6495.4 | 1813.5 | · | · | · | 766622.4 | 542.9 | 907.5 | |
| P/B | 1.6 | 303.4 | 395.6 | 383.8 | 92.3 | 143.7 | 149.1 | 198.9 | 481.9 | 401.8 | 269.2 | 268.4 | |
| P / Tangible Book | 1.6 | · | 395.6 | 383.8 | 92.3 | 143.7 | · | · | · | · | · | · | |
| P / Cash Flow | -4.6 | -51.8 | -435.7 | -354.7 | -131.0 | -469.7 | -442.3 | -943.3 | -1938.0 | -477.0 | -1322.1 | -3185.0 | |
| P / FCF | -4.5 | -51.8 | -435.4 | -354.0 | -131.0 | -468.8 | -441.1 | -940.5 | -1919.0 | -466.0 | -1280.4 | -3034.3 | |
| Earnings Yield | -4.1% | -2.4% | -0.25% | -0.29% | -0.85% | -0.30% | -0.25% | -0.08% | -0.04% | -0.12% | -0.12% | -0.08% |
Laporan Laba Rugi
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $1M | · | · | $0 | $0 | · | · | · | · | · | · | · | · | $0 | · | |
| R&D Expense | $19M | $18M | $106M | $20M | $12M | $11M | $233.2K | $2M | $6M | $6M | $5M | $5M | $4M | $5M | $6M | $5M | |
| SG&A Expense | $9M | $8M | $9M | $6M | $9M | $4M | $5M | $4M | $4M | $5M | $4M | $5M | $5M | $6M | $5M | $4M | |
| Operating Expenses | $28M | $26M | $114M | $26M | $21M | $14M | $7M | $11M | $10M | $11M | $10M | $10M | $9M | $11M | $11M | $9M | |
| Operating Income | $-26M | $-25M | $-103M | $-26M | $-21M | $-14M | $-7M | $-11M | $-10M | $-11M | $-10M | $-10M | $-9M | $-11M | $-11M | $-9M | |
| Other Non-op | $2M | $1M | · | $1M | $-760.0K | $-924.0K | $110.1K | $1M | · | · | $512.2K | $611.0K | · | · | · | · | |
| Income Tax | $0 | $0 | $2M | $0 | $0 | $0 | · | · | · | · | · | · | · | · | · | · | |
| Net Income | $-25M | $-23M | $-23M | $-25M | $-22M | $-15M | $-7M | $-10M | $-10M | $-11M | $-9M | $-9M | $-8M | $-10M | $-10M | $-9M | |
| EPS (Basic) | · | · | · | · | · | $-0.04 | $-0.11 | $-0.15 | $-0.16 | $-0.17 | $-0.14 | $-0.14 | $-0.13 | $-0.17 | $-0.20 | $-0.16 | |
| EPS (Diluted) | · | · | · | · | · | · | $-0.24 | $-0.15 | $-0.16 | $-0.04 | $-0.14 | $-0.14 | $-0.13 | $-0.17 | $-0.20 | $-0.16 | |
| Shares (Basic) | · | · | · | · | · | 64,522,257 | · | 64,483,958 | 64,483,848 | 64,457,233 | · | 64,349,709 | 64,276,184 | 60,350,127 | · | 52,423,944 | |
| Shares (Diluted) | · | · | · | · | · | · | · | 64,483,958 | 64,483,848 | 64,522,257 | · | 64,349,709 | 64,276,184 | 64,457,233 | · | 52,423,944 | |
| EBITDA | $-26M | · | · | $-26M | $-21M | · | · | $-11M | $-10M | $-11M | · | $-10M | $-9M | $-11M | · | $-9M |
Neraca
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $172M | $189M | $213M | $133M | $153M | $6M | $11M | $14M | $22M | $31M | $42M | $49M | $58M | $65M | $48M | $52M | |
| Receivables | $0 | $0 | $18M | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Prepaid Expense | $7M | $6M | $5M | $1M | $2M | $378.0K | $371.3K | $1M | $1M | $2M | $2M | $3M | $2M | $3M | $3M | $2M | |
| Other Current Assets | $7M | $6M | $5M | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Current Assets | $179M | $196M | $237M | $135M | $154M | $6M | $11M | $16M | $24M | $33M | $44M | $52M | $60M | $68M | $51M | $54M | |
| PP&E (Net) | $876.0K | $929.0K | $846.0K | $782.0K | $193.0K | · | · | · | · | · | · | $133.0K | $167.9K | $200.7K | · | $288.1K | |
| PP&E (Gross) | · | · | · | · | · | · | · | · | · | · | · | $3M | $3M | $3M | · | $3M | |
| Accum. Depreciation | · | · | · | · | · | · | · | · | · | · | · | $3M | $2M | $2M | · | $2M | |
| Other Non-current Assets | $1M | $1M | $1M | $1M | $1M | · | · | · | · | · | · | · | · | · | · | · | |
| Total Assets | $183M | $199M | $240M | $138M | $157M | $6M | $11M | $16M | $24M | $34M | $45M | $53M | $62M | $69M | $52M | $56M | |
| Accounts Payable | · | · | · | · | · | $104.7K | $329.3K | $581.8K | $950.8K | $755.5K | $868.1K | $329.9K | $241.5K | $480.2K | $970.2K | $852.1K | |
| Accrued Liabilities | $7M | $4M | $16M | $9M | $8M | $3M | $5M | $3M | $3M | $4M | $5M | $5M | $6M | $6M | $7M | $6M | |
| Current Liabilities | $19M | $14M | $36M | $20M | $17M | $3M | $6M | $4M | $4M | $5M | $7M | $6M | $7M | $7M | $9M | $8M | |
| Capital Leases | $966.0K | $1M | $1M | $1M | $1M | · | · | · | · | · | $66.8K | $262.1K | $448.8K | · | · | $95.6K | |
| Total Liabilities | $20M | $15M | $37M | $22M | $18M | $3M | $6M | $4M | $4M | $5M | $7M | $7M | $7M | $7M | $9M | $8M | |
| Common Stock | $28.0K | $28.0K | $28.0K | $14.0K | $14.0K | $64.5K | $64.5K | $64.5K | $64.5K | $64.5K | $64.4K | $64.4K | $64.3K | $64.2K | $54.4K | $52.4K | |
| Paid-in Capital | $379M | $375M | $371M | $192M | $190M | $500M | $500M | $498M | $497M | $496M | $495M | $494M | $493M | $492M | $462M | $457M | |
| Retained Earnings | $-220M | $-195M | $-172M | $-79M | $-55M | $-497M | $-494M | $-487M | $-477M | $-467M | $-456M | $-447M | $-438M | $-430M | $-420M | $-409M | |
| Stockholders' Equity | $163M | $184M | $203M | $117M | $139M | $3M | $5M | $11M | $20M | $29M | $38M | $47M | $55M | $62M | $43M | $48M | |
| Liabilities + Equity | $183M | $199M | $240M | $138M | $157M | $6M | $11M | $16M | $24M | $34M | $45M | $53M | $62M | $69M | $52M | $56M | |
| Shares Outstanding | 27,756,044 | 27,571,935 | 27,556,767 | 13,892,516 | 13,892,562 | 64,532,091 | 64,483,958 | 64,483,958 | 64,483,958 | 64,450,835 | 64,393,744 | 64,368,843 | 64,313,333 | 64,245,224 | 54,377,798 | 52,423,944 |
Arus Kas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $4M | $4M | $5M | $2M | $6M | $1M | $1M | $1M | $1M | $1M | $908.4K | $887.8K | $858.1K | $870.2K | $899.2K | $914.0K | |
| Restructuring | · | · | · | · | · | · | · | $5M | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-19M | $-9M | $-27M | $-18M | $-22M | $-11M | $-4M | $-8M | $-9M | $-11M | $-8M | $-9M | $-7M | $-12M | $-8M | $-9M | |
| CapEx | $13.0K | $147.0K | $193.0K | $586.0K | $140.0K | $0 | $0 | $0 | $2.5K | $7.4K | $801 | $7.9K | $10.5K | $2.2K | $1 | $2.5K | |
| Investing Cash Flow | $2M | $-8M | $-72M | $-586.0K | $-140.0K | $0 | $30.0K | $0 | $-2.5K | $-7.4K | $-801 | $-7.9K | $-10.5K | $-2.2K | $-1 | $-2.5K | |
| Stock Issued | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $29M | · | · | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | · | · | · | · | $29M | · | · | |
| Financing Cash Flow | $136.0K | $-7M | $179M | $-1M | $147M | $-1M | $0 | $0 | $500 | $4.9K | $999 | $61.6K | $20.1K | $29M | · | · | |
| Net Change in Cash | $-18M | $-24M | $80M | $-19M | $123M | $-12M | $-4M | $-8M | $-9M | $-11M | $-8M | $-9M | $-7M | $17M | $-4M | $-9M | |
| Free Cash Flow | · | · | · | · | · | · | · | · | · | $-11M | · | · | · | $-12M | · | · |
Profitabilitas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -14.6% | · | · | -32.0% | -24.0% | · | · | · | -23.4% | -20.8% | · | -16.9% | -13.0% | -13.8% | · | -10.4% | |
| ROE | -16.4% | · | · | -38.4% | -27.4% | · | · | · | -27.0% | -23.6% | · | -19.4% | -14.9% | -15.9% | · | -11.8% |
Likuiditas & Solvabilitas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 9.7 | · | · | 6.6 | 9.2 | · | · | · | 5.5 | 6.3 | · | 8.1 | 9.2 | 10.1 | · | 6.9 | |
| Quick Ratio | 9.3 | · | · | 6.6 | 9.1 | · | · | · | 5.1 | 5.9 | · | 7.7 | 8.8 | 9.6 | · | 6.7 |
Efisiensi
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Receivables Turnover | 0.0 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
Per Saham
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $5.88 | · | · | $8.40 | $10.02 | · | · | · | $0.31 | $0.45 | · | $0.72 | $0.85 | $0.97 | · | $0.92 | |
| Cash Flow / Share | · | · | · | · | · | · | · | · | · | $-0.16 | · | · | · | $-0.19 | · | · | |
| Cash / Share | $6.18 | · | · | $9.59 | $10.99 | · | · | · | $0.35 | $0.49 | · | $0.77 | $0.90 | $1.01 | · | $0.98 | |
| EPS (TTM) | $-0.59 | $-0.49 | · | $-0.59 | $-0.59 | $-0.59 | · | $-0.49 | $-0.48 | $-0.45 | · | $-0.64 | $-0.66 | $-0.78 | · | $-1.02 |
Valuasi (TTM)
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-96M | $-93M | · | $-69M | $-54M | $-42M | · | $-40M | $-39M | $-37M | · | $-38M | $-37M | $-42M | · | $-54M | |
| Market Cap | $500M | · | · | $165M | $224M | · | · | · | $1.81B | $19.34B | · | $9.66B | $11.19B | $8.09B | · | $2.88B | |
| P/E | -30.5 | -37.5 | · | -20.2 | -27.4 | -35.6 | · | -34.7 | -58.3 | -666.7 | · | -234.4 | -263.6 | -161.5 | · | -53.9 | |
| P/B | 3.1 | · | · | 1.4 | 1.6 | · | · | · | 90.0 | 668.8 | · | 207.4 | 204.2 | 130.2 | · | 59.9 | |
| P / Tangible Book | 3.1 | 2.8 | · | 1.4 | 1.6 | 401.5 | · | 96.4 | 90.0 | 668.8 | · | 207.4 | 204.2 | 130.2 | · | 59.9 | |
| P / Cash Flow | · | · | · | · | · | · | · | · | · | -1839.9 | · | · | · | -697.4 | · | · | |
| Earnings Yield | -3.3% | -2.7% | · | -5.0% | -3.7% | -2.8% | · | -2.9% | -1.7% | -0.15% | · | -0.43% | -0.38% | -0.62% | · | -1.8% |
Periode terbaru di sebelah kiri · nilai null ditampilkan sebagai ·
Laporan Keuangan Laporan laba rugi, neraca, arus kas — tahunan, 5 tahun terakhir
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Pendapatan | $11M | · | $10.0K | $75.0K | $1M |
| Margin Operasi % | -1407.5% | · | -392752.9% | -63204.4% | -5470.7% |
| Laba Bersih | $-154M | $-38M | $-37M | $-47M | $-63M |
| EPS Dilusian | · | $-0.59 | $-0.58 | $-0.89 | $-1.23 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Rasio Lancar | 6.6 | 1.9 | 6.4 | 5.7 | 7.7 |
| Rasio Cepat | 6.4 | 1.9 | 6.1 | 5.4 | 7.6 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Arus Kas Bebas | $-72M | $-31M | $-35M | $-47M | $-58M |
Pemilik institusional (13F) 82 pengaju · $526.1M total · Per tanggal 30 Juni 2026
Institusi yang melaporkan kepemilikan saham ini dalam SEC Form 13F triwulanan mereka. Hanya posisi panjang; satu pengaju dapat muncul dua kali untuk leg opsi terpisah. Kaki put/call offset yang besar biasanya mencerminkan pembuatan pasar atau inventaris yang dilindungi, bukan keyakinan arah.
Pemegang
82
Nilai yang dipegang
$526.1M
Posisi baru
32
Posisi yang keluar
12
Aktivitas institusional — Q2 2026 vs kuartal sebelumnya
| Posisi baru | Posisi yang keluar | Meningkat | Menurun | Perubahan bersih saham |
|---|---|---|---|---|
| 32 (+15 vs Kuartal sebelumnya) | 12 (+2 vs Kuartal sebelumnya) | 17 (0 vs Kuartal sebelumnya) | 14 (+6 vs Kuartal sebelumnya) | +4.0M |
Dibandingkan dengan Q1 2026. Pengajuan Formulir 13F SEC jatuh tempo dalam waktu 45 hari setelah akhir kuartal ditambah kelonggaran singkat untuk pengaju terlambat — kuartal yang masih dalam jangka waktu tersebut dilewati demi pasangan terakhir yang dilaporkan sepenuhnya.
| Institusi | Nilai | Saham | % dari 13F yang dilacak | Tipe |
|---|---|---|---|---|
| FMR LLC | $74.403.252 | 4.133.514 | 14,14% | Saham |
| BVF INC/IL | $49.477.734 | 2.748.763 | 9,40% | Saham |
| Fairmount Funds Management LLC | $49.461.588 | 2.747.866 | 9,40% | Saham |
| Venrock Adviser, LLC | $38.404.368 | 2.133.576 | 7,30% | Saham |
| Logos Global Management LP | $34.200.000 | 1.900.000 | 6,50% | Saham |
| FCPM III SERVICES B.V. | $30.201.336 | 1.677.852 | 5,74% | Saham |
| Balyasny Asset Management L.P. | $29.932.506 | 1.662.917 | 5,69% | Saham |
| Vestal Point Capital, LP | $29.340.000 | 1.630.000 | 5,58% | Saham |
| Opaleye Management Inc. | $23.748.318 | 1.319.351 | 4,51% | Saham |
| BlackRock, Inc. | $22.891.716 | 1.271.762 | 4,35% | Saham |
| TANG CAPITAL MANAGEMENT LLC | $20.880.000 | 1.160.000 | 3,97% | Saham |
| VANGUARD CAPITAL MANAGEMENT LLC | $13.819.590 | 767.755 | 2,63% | Saham |
| MILLENNIUM MANAGEMENT LLC | $7.269.462 | 403.859 | 1,38% | Saham |
| GEODE CAPITAL MANAGEMENT, LLC | $6.923.843 | 384.576 | 1,32% | Saham |
| JENNISON ASSOCIATES LLC | $6.813.126 | 378.507 | 1,30% | Saham |
| RTW INVESTMENTS, LP | $6.711.408 | 372.856 | 1,28% | Saham |
| NEXTBio Capital Management LP | $6.711.408 | 372.856 | 1,28% | Saham |
| VANGUARD GROUP INC | $6.612.021 | 557.506 | 1,26% | Saham |
| Remedium Capital Partners, LLC | $6.502.500 | 361.250 | 1,24% | Saham |
| STATE STREET CORP | $5.680.566 | 315.587 | 1,08% | Saham |
| AMERIPRISE FINANCIAL INC | $5.446.224 | 302.568 | 1,04% | Saham |
| Point72 Asset Management, L.P. | $5.400.000 | 300.000 | 1,03% | Saham |
| MARSHALL WACE, LLP | $3.857.400 | 214.300 | 0,73% | Saham |
| PERCEPTIVE ADVISORS LLC | $3.724.956 | 206.942 | 0,71% | Saham |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $3.398.454 | 188.803 | 0,65% | Saham |
| TWO SIGMA INVESTMENTS, LP | $3.363.732 | 186.874 | 0,64% | Saham |
| STEMPOINT CAPITAL LP | $3.282.876 | 182.382 | 0,62% | Saham |
| UBS Group AG | $3.153.276 | 175.182 | 0,60% | Saham |
| NORTHERN TRUST CORP | $2.498.004 | 138.778 | 0,47% | Saham |
| Exome Asset Management LLC | $2.299.842 | 127.769 | 0,44% | Saham |
| SECTORAL ASSET MANAGEMENT INC | $2.183.400 | 121.300 | 0,42% | Saham |
| Woodline Partners LP | $1.700.784 | 94.488 | 0,32% | Saham |
| VANGUARD FIDUCIARY TRUST CO | $1.354.050 | 75.225 | 0,26% | Saham |
| Burkehill Global Management, LP | $1.332.000 | 74.000 | 0,25% | Saham |
| Blackstone Inc. | $1.127.646 | 62.647 | 0,21% | Saham |
| SILVERARC CAPITAL MANAGEMENT, LLC | $1.063.872 | 59.104 | 0,20% | Saham |
| Y-Intercept (Hong Kong) Ltd | $914.832 | 50.824 | 0,17% | Saham |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $904.644 | 50.258 | 0,17% | Saham |
| Nuveen, LLC | $857.322 | 47.629 | 0,16% | Saham |
| Bank of New York Mellon Corp | $824.004 | 45.778 | 0,16% | Saham |
| Stonepine Capital Management, LLC | $720.000 | 40.000 | 0,14% | Saham |
| BANK OF AMERICA CORP /DE/ | $464.778 | 25.821 | 0,09% | Saham |
| RHUMBLINE ADVISERS | $458.766 | 25.487 | 0,09% | Saham |
| MOORE CAPITAL MANAGEMENT, LP | $450.000 | 25.000 | 0,09% | Saham |
| Squarepoint Ops LLC | $434.988 | 24.166 | 0,08% | Saham |
| AMERICAN CENTURY COMPANIES INC | $410.490 | 22.805 | 0,08% | Saham |
| TWO SIGMA ADVISERS, LP | $385.450 | 32.500 | 0,07% | Saham |
| WELLS FARGO & COMPANY/MN | $354.600 | 19.700 | 0,07% | Saham |
| ADAR1 Capital Management, LLC | $328.950 | 18.275 | 0,06% | Saham |
| Virtus Investment Advisers, LLC | $328.644 | 18.258 | 0,06% | Saham |
Aktivis & pemilik 5%+ 4 saham
Investor yang mengajukan Jadwal 13D SEC — kepemilikan manfaat di atas 5% dengan niat untuk memengaruhi penerbit (kepemilikan aktivis, kampanye dewan, M&A). Setiap baris menunjukkan status terbaru yang diketahui dari posisi pengaju tersebut.
| Pengaju | Diajukan | Kepemilikan | Status | Tujuan | Pengajuan |
|---|---|---|---|---|---|
| Fairmount Funds Management LLC, Fairmount Healthcare Fund II L.P., Peter Harwin, Tomas Kiselak ×3 pengajuan | 20 Juli 2026 | 16,52% | Amandemen | Investasi pasif | SEC |
| Adage Capital Management, L.P., Robert Atchinson, Phillip Gross ×2 pengajuan | 20 Juni 2025 | 0,37% | Amandemen | · | SEC |
| 8 Mei 2024 | · | Pengajuan awal | · | SEC | |
| New Enterprise Associates 10, Limited Partnership, NEA Partners 10, Limited Partnership, New Enterprise Associates 13, L.P., NEA Partners 13, L.P., NEA 13 GP, LTD, Anthony A. Florence, Jr, Mohamad H. Makhzoumi, Scott D. Sandell ×4 pengajuan | 29 Feb. 2024 | · | Pengajuan awal | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Orang dalam perusahaan 34 orang dalam · 16 pejabat · 18 direktur
| Orang Dalam | Peran | Aktivitas terakhir | Saham dimiliki | Beli 12m | Jual 12m | Bersih 12m |
|---|---|---|---|---|---|---|
| Joshua T Brumm | Chief Executive Officer | 18 Sep. 2026 S | 271.765 | 0 | 3 | $-920.842 |
| Harout Semerjian | Chief Executive Officer | 12 Jan. 2024 A | 25.000 | 0 | 0 | $0 |
| Richard William Scalzo | Chief Financial Officer | 16 Sep. 2026 S | 19.730 | 0 | 2 | $-30.172 |
| Brian M. Hahn | SVP Finance, CFO | 18 Juni 2024 P | 70.643 | 0 | 0 | $0 |
| Jonathan Mcneill | President and COO | 18 Sep. 2026 S | 134.588 | 0 | 3 | $-446.912 |
| Jan Pinkas | Chief Scientific Officer | 16 Sep. 2026 S | 21.581 | 0 | 2 | $-34.949 |
| Barbara Harlin Bispham | General Counsel and Corporate Secretary. | 16 Sep. 2026 S | 18.710 | 0 | 2 | $-33.010 |
| Ellie Eunkyung Im | Chief Medical Officer | 16 Sep. 2026 S | 21.446 | 0 | 2 | $-33.082 |
| Ryan Lynch | Treasurer, Senior Vice President of Finance and Chief Accounting Officer. | 16 Sep. 2026 S | 13.631 | 0 | 2 | $-12.661 |
| Christopher Grant Doughty | Chief Business Officer | 15 Des. 2025 A | 62.194 | 0 | 0 | $0 |
| Edwin Rock | Chief Medical Officer | 21 Juni 2024 P | 680.403 | 0 | 0 | $0 |
| Bruce S Johnson | SVP & Chief Commercial Officer | 12 Jan. 2024 A | 138.980 | 0 | 0 | $0 |
| Chinmaya Rath | SVP and Chief Business Officer | 12 Jan. 2024 A | · | 0 | 0 | $0 |
| Armand Girard | SVP, Chief Business Officer | 11 Nov. 2022 P | 29.161 | 0 | 0 | $0 |
| John L. Magnani | SVP of Research, CSO | 11 Nov. 2022 P | 366.078 | 0 | 0 | $0 |
| Helen M. Thackray | SVP Clinical Development, CMO | 20 Jan. 2021 A | 183.115 | 0 | 0 | $0 |
| Alexandra Balcom | Direktur | 2 Juni 2026 A | · | 0 | 0 | $0 |
| Susan Moran | Direktur | 2 Juni 2026 A | · | 0 | 0 | $0 |
| Jonathan Violin | Direktur | 2 Juni 2026 A | · | 0 | 0 | $0 |
| David Charles Lubner | Direktur | 2 Juni 2026 A | · | 0 | 0 | $0 |
| Rachel K. King | Direktur | 1 Mei 2024 A | 515.194 | 0 | 0 | $0 |
| Scott Koenig | Direktur | 1 Mei 2024 A | 36.750 | 0 | 0 | $0 |
| Scott Thomas Jackson | Direktur | 1 Mei 2024 A | 5.250 | 0 | 0 | $0 |
| Mark Alan Goldberg | Direktur | 1 Mei 2024 A | 24.828 | 0 | 0 | $0 |
| Timothy R Pearson | Direktur | 1 Mei 2024 A | 24.650 | 0 | 0 | $0 |
| Patricia S Andrews | Direktur | 1 Mei 2024 A | 58.608 | 0 | 0 | $0 |
| JUNIUS DANIEL M | Direktur | 1 Mei 2024 A | 98.459 | 0 | 0 | $0 |
| James M Barrett | Direktur | 18 Mei 2018 A | 4.995.664 | 0 | 0 | $0 |
| John J. Baldwin | Direktur | 29 Juni 2016 M | 1.210 | 0 | 0 | $0 |
| Franklin H Top JR | Direktur | 17 Mei 2016 A | 12.294 | 0 | 0 | $0 |
| Michael A Henos | Direktur | 15 Juli 2015 A | 469.454 | 0 | 0 | $0 |
| William M. Gust | Direktur | 15 Jan. 2014 C | 409.947 | 0 | 0 | $0 |
| Scott D. Sandell | Pemilik 10% | 26 Jan. 2023 S | 2.237.196 | 0 | 0 | $0 |
| Peter J Barris | Pemilik 10% | 10 Mei 2018 X | 4.995.664 | 0 | 0 | $0 |
Orang dalam dari pengajuan SEC Form 3/4/5; bersih = hanya P/S pasar terbuka
Kepemilikan ETF Dimiliki oleh 10 ETF
Bobot mencerminkan kepemilikan ekuitas langsung (N-PORT) saja; dana berbasis leverage atau derivatif mungkin memiliki eksposur swap tambahan yang tidak ditampilkan.
| Dana | Bobot | Unit | Per tanggal | Sumber |
|---|---|---|---|---|
| IWC · iShares Trust | 0,10% | 72.879 SH | 11 Sep. 2026 | Harian |
| IWO · iShares Trust | 0,03% | 202.796 SH | 11 Sep. 2026 | Harian |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,02% | 23.282 SH | 19 Agu 2026 | Harian |
| IWM · iShares Trust | 0,01% | 544.047 SH | 11 Sep. 2026 | Harian |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 124.281 SH | 19 Agu 2026 | Harian |
| RSSL · Global X Funds | 0,01% | 10.277 NS | 31 Juli 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 83.801 SH | 19 Agu 2026 | Harian |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 661.946 SH | 19 Agu 2026 | Harian |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 1.832 SH | 19 Agu 2026 | Harian |
| VHT · VANGUARD WORLD FUND | 0,00% | 39.408 SH | 19 Agu 2026 | Harian |
CBIO Konsensus Analis Opini analis bullish dan bearish, target harga 12 bulan, potensi kenaikan
peringkat · 15 analis
BELI
Target median
$28.00
+95,5%
6 40,0%
Beli Kuat
7 46,7%
Beli
2 13,3%
Tahan
0 0,0%
Jual
0 0,0%
Jual Kuat
Target Harga 12 Bulan
5 analis · 2026-09-30Target rata-rata $30.60 +113,7%
← Di bawah semua target
Harga saat ini $14.32
Rendah$27.00
Rata-rata$30.60
Tinggi$35.00
Perbandingan rekan (sub-industri GICS) Metrik utama vs rekan sektor
Dasar FY, harga per penutupan akhir tahun fiskal terakhir setiap perusahaan.
| Ticker | Kapitalisasi Pasar | P/E | Pendapatan YoY | Margin Bersih | ROE | Margin Kotor |
|---|---|---|---|---|---|---|
| CBIO | $327M | -24.2 | -86.7% | -1419.6% | -90.0% | · |
| ALT | $400M | -3.6 | 105.0% | -214861.0% | -45.6% | · |
| ALLO | $314M | -1.6 | -76.8% | · | -59.9% | · |
| MPLT | $773M | -0.9 | · | · | -151.1% | · |
| MNPR | · | · | · | · | · | · |
| NGNE | $319M | -4.9 | · | · | -33.6% | · |
| ZURA | · | · | · | · | · | · |
| CAPR | $1.66B | -12.8 | -11.6% | · | -51.1% | · |
| PROK | · | · | 1075.0% | -7725.2% | 6.9% | · |
| PBYI | $300M | 9.8 | -0.91% | 13.6% | 26.5% | · |
| RGNX | $733M | -3.8 | 104.5% | -113.8% | -122.5% | · |
Metrik Saya Daftar pantauan pribadi Anda — baris yang dipilih dari Fundamental Lengkap
Pilih metrik yang penting bagi Anda — klik + di sebelah baris mana pun di Fundamental Lengkap di atas.
Pilihan Anda disimpan dan mengikuti Anda di semua ticker.
Sumber: SEC 10-Q diajukan Jul 30, 2026